Ausdal Financial Partners’s Novo Nordisk NVO Stock Holding History

Ausdal Financial Partners’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$223K	Buy	+6,070	New	+$288K	0.01%	893
2025 Q3	–	Sell	-9,100	Closed	-$628K	–	949
2025 Q2	$628K	Buy	+9,100	New	+$619K	0.04%	368
2024 Q4	–	Sell	-3,841	Closed	-$457K	–	584
2024 Q3	$457K	Buy	3,841 +200	+5%	+$26.7K	0.05%	331
2024 Q2	$520K	Buy	3,641 +230	+7%	+$30.5K	0.06%	284
2024 Q1	$438K	Buy	3,411 +292	+9%	+$34.8K	0.05%	294
2023 Q4	$323K	Sell	3,119 -240	-7%	-$23.7K	0.04%	335
2023 Q3	$305K	Buy	+3,359	New	+$296K	0.04%	334
2016 Q1	–	Sell	-8	Closed	–	–	762
2015 Q4	$0	Buy	+8	New	+$221	﹤0.01%	1324

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Ausdal Financial Partners's NVO Position: Q1 2026 in Review

Ausdal Financial Partners opened a new position in Novo Nordisk (NVO) in Q1 2026: 6,070 shares worth $223K. The stake represents 0.01% of the portfolio and ranks #893 among its holdings. This is a return to the name: Ausdal Financial Partners previously reported a position in NVO as recently as Q2 2025.

Ausdal Financial Partners first reported a position in NVO in Q4 2015 and has held it in 8 quarters since. The position peaked at $628K in Q2 2025. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Ausdal Financial Partners held 6,070 shares of Novo Nordisk worth $223K as of Q1 2026.
Novo Nordisk was a new Ausdal Financial Partners position in Q1 2026.
Novo Nordisk made up 0.01% of Ausdal Financial Partners's portfolio in Q1 2026, its #893 holding.
Ausdal Financial Partners first reported a position in Novo Nordisk in Q4 2015 and has held it in 8 quarters since.
Ausdal Financial Partners's Novo Nordisk position peaked at $628K in Q2 2025.
1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Ausdal Financial Partners's 13F filing for Q1 2026, filed 12 May 2026.